Abiopharma

Zimmer Biomet Holdings, Inc. Notification

Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®

Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook

Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results

Agenus Inc. - Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness

Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness

Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results

Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia

BD Receives FDA 510(k) Clearance for EnCorEnCompass™ Breast Biopsy and Tissue Removal System

Takeda to Hold Earnings Call for Fiscal Year 2025 3rd Quarter on January 29